No.96/A /9/1, 42nd cross, 3rd Main, 8th BIock, Jayanagar Bengaluru

A tumour board is where cancer treatment decisions actually get made. Not in a single consultation room with one doctor, but in a meeting where the surgical oncologist, the medical oncologist, the radiation oncologist, the pathologist, and the radiologist all look at the same case at the same time. Each of them sees the diagnosis differently. The surgeon is thinking about what can be removed and how. The medical oncologist is thinking about whether chemotherapy before surgery changes what the surgeon can achieve. The pathologist is the one who actually knows what the tissue says. The radiologist is the one who can tell everyone what the scan is really showing. No one of them has the full picture alone.The point of the tumour board is that the treatment plan comes out of that room, not from whichever specialist the patient happened to see first.

According to Dr. Sandeep Nayak, Best Cancer Treatment in Bangalore, “A tumour board isn’t a formality. It’s where the treatment plan gets stress-tested by people who might disagree with each other. That disagreement is the whole point. A plan that survives a pathologist questioning the staging and a radiation oncologist questioning the sequencing is a plan the patient can rely on.”

Meet the Specialists Behind Your Cancer Care → Consult Our Oncology Team

Who Sits on a Tumour Board and What Each Person Actually Does?

Surgical oncologist
Assesses whether the tumour can be removed, what the operation involves, and whether surgery should come first or after systemic treatment. Also the person who knows whether a technically resectable tumour is actually worth operating on given the stage and the patient’s fitness. At MACS Clinic, this is Dr. Sandeep Nayak’s role reviewing how the full treatment plan is built around what surgery can and cannot achieve.

Medical oncologist
Determines which drugs are appropriate, in which sequence, and at what dose. Weighs in on whether neoadjuvant chemotherapy before surgery is worth attempting, and what adjuvant treatment follows. Also the specialist managing systemic disease, targeted therapy, and immunotherapy decisions.

Radiation oncologist
Decides whether radiation has a role, when it fits relative to surgery and chemotherapy, and what the field and dose should be. For some cancers rectal cancer, head and neck cancers, cervical cancer the radiation oncologist’s input is as central to the plan as the surgeon’s.

Pathologist
The person the whole board relies on. Confirms the cancer type, grade, margin status, receptor and molecular profile from the biopsy. Everything else in the treatment plan is built on what the pathologist reports. A wrong or incomplete pathology read makes every other decision downstream unreliable.

Radiologist
Interprets the staging scans CT, MRI, PET and answers the clinical questions the rest of the board is asking. Whether a lymph node is suspicious or reactive. Whether a liver lesion is a metastasis or incidental. Whether the tumour margin is technically clear. The radiologist’s read of the imaging is what the surgeon and oncologist are working from.

Additional specialists when the case calls for it
Genetic counsellors for hereditary cancer cases. Interventional radiologists when biopsy or drainage decisions are involved. Palliative care physicians for advanced disease. Fertility specialists for young patients facing gonadotoxic treatment. Plastic surgeons for reconstructive planning in head and neck or breast cases. The board expands to match what the case actually needs.

Why the Tumour Board Matters More Than Any Single Consultation?

A patient who sees a surgeon first gets a surgical perspective on their cancer. A patient who sees a medical oncologist first gets a systemic treatment perspective. Neither is wrong but neither is complete either.

What changes when all three disciplines are in the same room is that the plan gets built on the full picture, not on the perspective of whichever specialist happened to see the patient first. Treatment sequence decisions whether surgery or chemotherapy comes first, whether radiation is needed at all, whether the patient’s fitness allows the intended plan are made with everyone’s input simultaneously rather than through a chain of separate referrals that may or may not talk to each other.

Studies consistently show that tumour board review changes the treatment plan in a meaningful percentage of cases sometimes confirming what the primary specialist recommended, sometimes revising it significantly. The revision isn’t a failure. It’s the board working as it should. For a practical look at how those three disciplines relate to each other and which one typically sees a patient first, the previous blog on Surgical, Medical, or Radiation Oncologist: Who Comes First covers that sequencing decision in full.

Why Choose MACS Clinic for Tumour Board Review?

Dr. Sandeep Nayak’s team at MACS Clinic runs every new cancer case through a formal tumour board before any treatment is confirmed. Surgical, medical, and radiation oncology input alongside pathology and radiology review — all in the same sitting, before the patient commits to a plan.

Patients here don’t get a treatment plan based on the opinion of whichever specialist they happened to see first. They get a plan built on staging, molecular profile, fitness assessment, and the combined input of every discipline relevant to their case. Those who want their case reviewed through a tumour board can reach the team at +91 8035740000

FAQs

Does every cancer patient need a tumour board review?

Every cancer patient benefits from one. Complex cases, advanced stage, borderline resectable, multiple treatment options need one most urgently.

What happens if the tumour board disagrees?

Discussion continues until a consensus plan emerges. Genuine disagreement usually means more information is needed, further staging, additional pathology before a decision is made.

How long does a tumour board meeting take?

Individual case discussions typically run 10 to 20 minutes. The meeting itself covers multiple cases and usually runs one to two hours.

Can a patient attend their own tumour board review?

At most centres, the meeting is a clinical discussion among specialists. The patient is presented by their treating doctor and the agreed plan is communicated afterward.

Disclaimer: This content is published for educational and informational purposes only.